Browsing: Policy

On my recent travels, I met a healthy, active man in his early 60s who runs a small business.  This year, his family’s monthly premium reached nearly $5,000 — more than a quarter of his pre‑tax income. He made the difficult choice to keep coverage only for his wife and two children, hoping to stay…

After months of anticipation, the Food and Drug Administration gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Kristin Gills knew the drill. She peed in the cup, and the doctor confirmed her suspicion. He prescribed antibiotics. Before she left Methodist Legacy ER & Urgent Care in Allen, Texas, Gills paid her $211 bill and figured that was the end of it. 

In September, Health and Human Services Secretary Robert F. Kennedy Jr. fired the two vice chairs of the U.S. Preventive Services Task Force. This move was both unsurprising and troubling. The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether private health insurers should be required to…

Health officials hoping to boost adoption of artificial intelligence in health care have been moving behind the scenes to address brewing conflict between states and the federal government over the technology.

For this week’s “STATus Report,” I report from arguably the birthplace of American democracy, and my hometown, Boston. What better place is there to be ahead of next week’s midterm elections? In this episode, STAT reporters from our D.C. bureau and across the newsroom discuss what the midterms could mean for vaccine policy, drug policy,…

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

On Wednesday night in Clive, Iowa, a parade of Make America Healthy Again activists and Republican candidates decried Big Agriculture, stressed the rise in chronic disease in America, and called for the Covid-19 vaccine to be removed from the market.